மையம் க்கு மூலக்கூறு நோயெதிர்ப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மையம் க்கு மூலக்கூறு நோயெதிர்ப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மையம் க்கு மூலக்கூறு நோயெதிர்ப்பு Today - Breaking & Trending Today

THE FULL STORY OF CUBA'S COVID-19 VACCINES – Times Caribbean Online


THE FULL STORY OF CUBA’S COVID-19 VACCINES
Posted on April 23, 2021 in Cuba, International // 0 Comments
Some 200 COVID-19 vaccines are being developed worldwide, and 23 candidates have advanced to phase III clinical trials (as of 25 March 2021). Though no other Latin American country has developed a vaccine of its own, two of the 23 now in phase III trials are Cuban: Soberana 02 and Abdala. And Cuba also has three other vaccine candidates in earlier stage trials: Soberana 01, Soberana Plus, and Mambisa. So how has Cuba managed to develop five COVID-19 vaccines in such a short time?
Cuba’s biotech sector is unique. It is entirely state-owned and free of private interests, with innovation channelled to meet public health needs and no profit-seeking in the domestic market. Dozens of research and development institutions collaborate, sharing resources and knowledge instead of competing, which facilitates a fast track from research and innovation to trials and a ....

United States , United Kingdom , Oxford Astrazeneca , Pichia Pastoris , Sinovac Butantan , Marlene Ram , Bharat Biotec , Idania Caballero , Centre For Molecular Immunology , Finlay Institute , Centre For Genetic Engineering , National Biopreparations Centre , Latin American , Soberana Plus , British Medical Journal , Molecular Immunology , National Biopreparations , Genetic Engineering , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பாரத் பயோடெக் , மையம் க்கு மூலக்கூறு நோயெதிர்ப்பு , ஃபின்லே நிறுவனம் , மையம் க்கு ஜெநெடிக் பொறியியல் , லத்தீன் அமெரிக்கன் , சோபேரான ப்லஸ் ,